136 related articles for article (PubMed ID: 10967105)
1. BAG1L enhances trans-activation function of the vitamin D receptor.
Guzey M; Takayama S; Reed JC
J Biol Chem; 2000 Dec; 275(52):40749-56. PubMed ID: 10967105
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of Bag1 proteins. Effects on androgen receptor transcriptional activity.
Knee DA; Froesch BA; Nuber U; Takayama S; Reed JC
J Biol Chem; 2001 Apr; 276(16):12718-24. PubMed ID: 11278763
[TBL] [Abstract][Full Text] [Related]
3. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A
Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465
[TBL] [Abstract][Full Text] [Related]
6. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
Herdick M; Carlberg C
J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
[TBL] [Abstract][Full Text] [Related]
7. Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells.
Kudoh M; Knee DA; Takayama S; Reed JC
Cancer Res; 2002 Mar; 62(6):1904-9. PubMed ID: 11912172
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
Saramäki A; Banwell CM; Campbell MJ; Carlberg C
Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
[TBL] [Abstract][Full Text] [Related]
10. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
11. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
13. The impact of chromatin organization of vitamin D target genes.
Carlberg C; Dunlop TW
Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the human vitamin D receptor by caspase-3.
Malloy PJ; Feldman D
Endocrinology; 2009 Feb; 150(2):679-86. PubMed ID: 18832097
[TBL] [Abstract][Full Text] [Related]
16. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
17. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
Bula CM; Bishop JE; Ishizuka S; Norman AW
Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
[TBL] [Abstract][Full Text] [Related]
18. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling.
Hsieh JC; Sisk JM; Jurutka PW; Haussler CA; Slater SA; Haussler MR; Thompson CC
J Biol Chem; 2003 Oct; 278(40):38665-74. PubMed ID: 12847098
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the molecular mechanism for the antagonistic action of a novel 1alpha,25-dihydroxyvitamin D(3) analogue toward vitamin D receptor function.
Ozono K; Saito M; Miura D; Michigami T; Nakajima S; Ishizuka S
J Biol Chem; 1999 Nov; 274(45):32376-81. PubMed ID: 10542279
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions.
Norman AW; Manchand PS; Uskokovic MR; Okamura WH; Takeuchi JA; Bishop JE; Hisatake JI; Koeffler HP; Peleg S
J Med Chem; 2000 Jul; 43(14):2719-30. PubMed ID: 10893309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]